Nanomagnets: a UCL-led revolution in breast cancer treatment

The diagnosis and treatment of breast cancer is undergoing a revolution, thanks to a magnetic nanoparticle technology developed by Professor Quentin Pankhurst. Replacing radioactive tracers, the technology can prevent unnecessary surgery, improve surgical outcomes, and increase patient access to the best standard of care. It’s both a research and commercial success story. Professor Pankhurst will share his fascinating journey from lab to market, creating his pioneering company Endomag and developing innovative products which have benefitted over 550,000 women around the world. 

A Housman Talk in collaboration with UCL Business
Many UCL academics have taken their research to benefit the wider world by creating businesses to commercialise their work. UCL Business (UCLB) is the commercialisation company of UCL, working to support academics to protect their idea and bring them to market through licensing and forming businesses. More information on the UCL Business website.